Embecta Corp.
$5.76-2.9%YTD-50.4%1Y-57.6%
Price updated 4m ago·X counts updated 2d ago
On X
The complete picture of $EMBC on X — how loud the conversation is right now, how it has trended over the last two weeks, and which way the crowd is leaning.
4X posts · last 7 days
AI verdictAI analysisGenerated by AI from underlying data
TickerTalks' own read on what's driving $EMBC — fundamentals, momentum, or an event — and whether it agrees with the X crowd.
What it does
Plain-English summary of the business — what they sell and how they make money.
Industry overviewAI analysisGenerated by AI from underlying data
Where Medical - Instruments & Supplies sits in its cycle right now — and what that implies for $EMBC.
Medical - Instruments & Supplies
No material change from last week — Procedure-volume normalization lifting surgical robotics and sterile supply demand.
What this means for $EMBC
Partial — Medical device company making pen needles, syringes, and safety devices for diabetes drug delivery, spun off from BD in 2022.
Industry benchmark
10-name peer basket
+3.6%YTD
+13.4%1Y
Fundamentals & catalyst
Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.
Key ratios
P/E
3.0How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.ROIC
17.9%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.Op margin
24.8%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.FCF yield
62.8%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).P/S
0.3Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.ROE
-14.0%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.Gross margin
58.8%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.D/E
-2.4Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.Past earnings
QuarterReportedActualEstimateSurprise
Q2 2026Aug 7, 2026$0.56$0.27+110.7%
Q1 2026May 5, 2026$0.27$0.42-35.7%
Q4 2025Feb 5, 2026$0.71$0.67+6.0%
Q3 2025Nov 25, 2025$0.50$0.70-28.6%
Next earningsTue, Nov 24·consensus EPS $0.31
Quarterly trend
QuarterRevenueYoYGrossOpEPSFCF
Q3 FY26$271.7M-8.1%52.3%17.9%$0.36$40.7M
Q2 FY26$221.8M-14.4%56.4%19.3%$-0.07$30.6M
Q1 FY26$261.2M-0.3%67.2%37.2%$0.75$16.6M
Q4 FY25$264.0M-7.7%59.1%24.4%$0.45$76.7M
Forward consensus
FYRevenueRangeEPSRangeAnalysts
FY26$1.0B$1.0B – $1.0B$1.83$1.82 – $1.843
FY27$1.1B$1.1B – $1.1B$1.76$1.75 – $1.773
FY28$1.1B$1.1B – $1.1B$1.95$1.53 – $2.483
FY29$1.1B$1.1B – $1.1B$2.96$2.95 – $2.971
FY30$1.1B$1.1B – $1.1B$3.06$3.05 – $3.071
Setup & momentum
Volume, range, and moving-average position — the technical setup driving short-term moves.
Right now
Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.6×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.26%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+25.5%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-17.7%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.
Float & profile
FloatMid float · 58.3M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today1.4% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.855-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.
Insider activity
Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.
SEC filings
Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.
Recent material filings
8-KAcquisition completedMay 158-K — Item 2.01: Acquisition completed · Item 7.01: Press release / Reg FD
+ 13 other (6 13Gs · 3 earnings 8-Ks · 2 10-Qs · 1 S-8) in window
Recent news
Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.
EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary DutyEMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Dutyembecta to Participate in Investor EventsEMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary DutyThe Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
More in Medical - Instruments & Supplies
Peers in the same group — one click to compare setups, fundamentals, and chatter.
Voices on X · last 7 days
No standout posts about $EMBC on X in the last 7 days.